Table 7.
Anticancer effects of quercetin via the intonation of cell signaling molecules.
| Pathways | Cancer | In Vitro/In Vivo | Dose | Mechanism | Outcome | Refs. |
|---|---|---|---|---|---|---|
| PTEN/PI3K/AKT | Breast | MCF-7 | 0, 20, 40, 60, 80, and 100 μmol/L | p-PI3K and p-AKT ↓ and PTEN ↑ |
|
[197] |
| Cell cycle | Breast | MDA-MB-231 | 20 µM | Cell cycle arrest |
|
[198] |
| Apoptosis | Oral | SAS | 40 µM | Induction of apoptosis |
|
[199] |
| Angiogenesis | Colorectal | HT-29 cells | 5 and 10 µg/mL | VEGF-A VEGFR-2 ↓ |
|
[200] |
| NF-κB p65 | Colorectal | HT-29 cells | 5 and 10 µg/mL | NF-κB p65 ↓ |
|
[200] |
| Invasion and angiogenesis | Esophageal | Eca109 | 5 μg/mL or 10 μg/mL | VEGF-A, MMP9, and MMP2 ↓ |
|
[201] |
| Cell cycle | Breast | T47D | 50 µM | Cells in G2/M phase and the G2/M cells ↑ |
|
[202] |
| Apoptosis | Breast | T47D | 50 µM | Induction of apoptosis |
|
[202] |
| Apoptosis | Oral | D10B and YD38 | 25 μM and 50 μM | Induction of apoptosis |
|
[203] |
| P53 | Breast | MDA-MB-453 | 100 µM | P53 ↑ |
|
[204] |
| Autophagy | Brain | U373MG | 25, 50, and 75 µM | Induction of autophagy |
|
[205] |
| EGFR pathway | Prostate | Rats | 200 mg/kg | EGFR ↓ |
|
[206] |
| JNK/ERK MAPK pathway | Leukemia | Mice | 120 mg/kg | JNK/ERK MAPK pathway ↓ |
|
[207] |
| Calcineurin/NFAT pathway | Breast | Mice | 34 mg/kg | Calcineurin/NFAT pathway ↓ |
|
[208] |
| STAT3 pathway | Pancreas | PATU-8988 and PANC-1 cells | 0, 20, 40, and 80 µM | STAT3, MMP2, MMP7↓ |
|
[209] |